Get started
Author

Miguel Ángel Viveros-Lugo

Observed names: Miguel A. Viveros-Lugo, Miguel Angel Viveros-Lugo
ORCID: 0009-0005-1569-1179
Observed ORCID: 0009-0005-1569-1179
OpenAlex ID: A5116842090
Body mass index is unrelated to the response to autologous hematopoietic stem cell transplantation in persons with multiple sclerosis
2025 · Danae García-Vélez, Mónica Daniela Salgado-Cabrera, et al. · Multiple Sclerosis and Related Disorders · 2
Glomerular filtration rate as a prognostic factor in persons with multiple myeloma: A single institution experience
2026 · Olivia Lira-Lara, Max Robles Nasta, et al. · Revista Colombiana de Nefrología
PDF
The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants
2026 · Michelle Lavoignet-Cisneros, Lidia Joanna Alberto-López, et al. · Transfusion and Apheresis Science
Early therapeutic response as a prognostic indicator in autologous HSCT for multiple sclerosis
2025 · Juan Carlos Olivares-Gazca, Miguel Ángel Viveros-Lugo, et al. · Journal of the Neurological Sciences
Assessing disability in multiple sclerosis: concordance between patient-recorded and neurologist-recorded EDSS ratings in a 10-year single-center experience
2025 · Mónica Daniela Salgado-Cabrera, Lidia Joanna Alberto-López, et al. · Multiple Sclerosis and Related Disorders
Predicting the response to hematopoietic stem cell transplantation in persons with multiple sclerosis: the significance of an early positive response
2025 · Miguel A. Viveros-Lugo, Gloria E. Cruz-Pérez, et al. · Bone Marrow Transplantation
Allogeneic HSCT in children with relapsed/refractory acute lymphoblastic leukemia: ambulatory or in-hospital?
2025 · Olivia Lira-Lara, Sofía Chávez-Martínez, et al. · Blood Global Hematology
Works count: 7
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type